271 related articles for article (PubMed ID: 29474405)
41. Protein-bound uremic toxins: new insight from clinical studies.
Liabeuf S; Drüeke TB; Massy ZA
Toxins (Basel); 2011 Jul; 3(7):911-9. PubMed ID: 22069747
[TBL] [Abstract][Full Text] [Related]
42. Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK/UCP2 signaling pathway.
Yang K; Xu X; Nie L; Xiao T; Guan X; He T; Yu Y; Liu L; Huang Y; Zhang J; Zhao J
Toxicol Lett; 2015 Apr; 234(2):110-9. PubMed ID: 25703824
[TBL] [Abstract][Full Text] [Related]
43. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
[TBL] [Abstract][Full Text] [Related]
44. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure.
Taki K; Nakamura S; Miglinas M; Enomoto A; Niwa T
J Ren Nutr; 2006 Jul; 16(3):199-203. PubMed ID: 16825019
[TBL] [Abstract][Full Text] [Related]
45. Uremic toxins promote accumulation of oxidized protein and increased sensitivity to hydrogen peroxide in endothelial cells by impairing the autophagic flux.
Rodrigues SD; Santos SS; Meireles T; Romero N; Glorieux G; Pecoits-Filho R; Zhang DD; Nakao LS
Biochem Biophys Res Commun; 2020 Feb; 523(1):123-129. PubMed ID: 31837804
[TBL] [Abstract][Full Text] [Related]
46. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
[TBL] [Abstract][Full Text] [Related]
47. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease.
Yeh YC; Huang MF; Liang SS; Hwang SJ; Tsai JC; Liu TL; Wu PH; Yang YH; Kuo KC; Kuo MC; Chen CS
Neurotoxicology; 2016 Mar; 53():148-152. PubMed ID: 26797588
[TBL] [Abstract][Full Text] [Related]
48. New insights into uremic toxicity.
Raff AC; Meyer TW; Hostetter TH
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):560-5. PubMed ID: 18941347
[TBL] [Abstract][Full Text] [Related]
49. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
Niwa T
Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
[TBL] [Abstract][Full Text] [Related]
50. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
Lin CJ; Wu V; Wu PC; Wu CJ
PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
[TBL] [Abstract][Full Text] [Related]
51. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
Fujii H; Nakai K; Fukagawa M
Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501
[TBL] [Abstract][Full Text] [Related]
52. Uremic toxins impair human bone marrow-derived mesenchymal stem cells functionality in vitro.
Idziak M; Pędzisz P; Burdzińska A; Gala K; Pączek L
Exp Toxicol Pathol; 2014 Jul; 66(4):187-94. PubMed ID: 24548687
[TBL] [Abstract][Full Text] [Related]
53. Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin.
Watanabe H; Noguchi T; Miyamoto Y; Kadowaki D; Kotani S; Nakajima M; Miyamura S; Ishima Y; Otagiri M; Maruyama T
Drug Metab Dispos; 2012 Jul; 40(7):1423-8. PubMed ID: 22513409
[TBL] [Abstract][Full Text] [Related]
54. Heritability and clinical determinants of serum indoxyl sulfate and p-cresyl sulfate, candidate biomarkers of the human microbiome enterotype.
Viaene L; Thijs L; Jin Y; Liu Y; Gu Y; Meijers B; Claes K; Staessen J; Evenepoel P
PLoS One; 2014; 9(5):e79682. PubMed ID: 24850265
[TBL] [Abstract][Full Text] [Related]
55. Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.
Yamamoto S; Kazama JJ; Omori K; Matsuo K; Takahashi Y; Kawamura K; Matsuto T; Watanabe H; Maruyama T; Narita I
Sci Rep; 2015 Sep; 5():14381. PubMed ID: 26395517
[TBL] [Abstract][Full Text] [Related]
56. Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney.
Miyamoto Y; Watanabe H; Noguchi T; Kotani S; Nakajima M; Kadowaki D; Otagiri M; Maruyama T
Nephrol Dial Transplant; 2011 Aug; 26(8):2498-502. PubMed ID: 21303967
[TBL] [Abstract][Full Text] [Related]
57. TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage.
Lu CL; Liao CH; Lu KC; Ma MC
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867359
[TBL] [Abstract][Full Text] [Related]
58. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial.
Esgalhado M; Kemp JA; Azevedo R; Paiva BR; Stockler-Pinto MB; Dolenga CJ; Borges NA; Nakao LS; Mafra D
Food Funct; 2018 Dec; 9(12):6508-6516. PubMed ID: 30468238
[TBL] [Abstract][Full Text] [Related]
59. Nox4 as a potential therapeutic target for treatment of uremic toxicity associated to chronic kidney disease.
Gorin Y
Kidney Int; 2013 Apr; 83(4):541-3. PubMed ID: 23538692
[TBL] [Abstract][Full Text] [Related]
60. The protein-bound uremic toxin p-cresyl-sulfate promotes intracellular ROS production and lipid peroxidation in 3T3-L1 adipose cells.
Koppe L; Croze ML; Monteiro EB; Benoit B; Bres E; Guebre-Egziabher F; Daleprane JB; Fouque D; Soulage CO
Biochimie; 2021 Oct; 189():137-143. PubMed ID: 34217821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
